Status:
NOT_YET_RECRUITING
Lipid Infusions to Optimize Nutrition Trial
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Bronchopulmonary Dysplasia
Neurodevelopmental Impairment
Eligibility:
All Genders
12-28 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion ...
Eligibility Criteria
Inclusion
- inborn \<28 weeks gestational age (GA) or ≤1000g birth weight (BW)
- survives until 12 hours after birth.
Exclusion
- Infants who are unable to be enrolled by 96 hours postnatal age
- Major anomaly
- Overt non-bacterial infection
- Infants likely to expire soon defined as limiting or withdrawal of intensive care recommended or requested by the parents.
Key Trial Info
Start Date :
March 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT06915441
Start Date
March 1 2026
End Date
December 31 2030
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030